dynorphins has been researched along with Muscle-Spasticity* in 2 studies
2 other study(ies) available for dynorphins and Muscle-Spasticity
Article | Year |
---|---|
Decreased dynorphin A (1-17) in the spinal cord of spastic rats after the compressive injury.
Spasticity in rat hindlimbs was induced by compressing cervical spinal cord with a wax ball. Ashworth score and H-reflex were measured 1 week after the surgery. The results showed that: (1) muscle spasm was detected in the hindlimbs a week after the operation and maintained at least 8 weeks, (2) in the spastic animals, dynorphin A (1-17)-ir decreased significantly in thoracic and lumbar segments of the spinal cord and (3) peripheral administration of kappa receptor agonist U50488H and electrical stimulation at 100 Hz effectively relieved the muscle spasm. Our data supported the note that the reduction of endogenous dynorphin A (1-17) might play an important role in the pathogenesis of spinally induced muscle spasticity and the replenishment of its shortage might relieve the spasticity. Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Cervical Vertebrae; Disability Evaluation; Dynorphins; Electric Stimulation; Female; Muscle Spasticity; Naloxone; Narcotic Antagonists; Radioimmunoassay; Rats; Rats, Wistar; Reflex; Spinal Cord; Spinal Cord Compression; Thoracic Vertebrae; Time Factors | 2005 |
66A-078:a kappa-opiate receptor agonist for amelioration of spinal spasticity.
The effect and mechanism of kappa opiate receptor agonist and high-frequency electrostimulation of acupoints in treating spinal spasticity were studied. The spinal spastic models were made by gradual mechanical compression on the cervical spinal cord of rabbits. 24 prepared rabbits were divided into 3 groups randomly, and each group with 8 rabbits was given intrathecally kappa-receptor agonist 66A-078, kappa-receptor antagonist +66A-078 and normal saline respectively. The degree of spasticity was quantified by both clinical score and electrophysiological examinations. The result showed that the spasticity was markedly inhibited by intrathecal injection of 66A-078 and that the kappa-receptor antagonist (naloxone) reversed this effect. We can infer that the antispastic effect of 66A-078 is mediated by kappa-receptors. This result is helpful in explaining the immediate antispastic mechanism of high-frequency electrostimulation of acupoints discussed in previous study. Topics: Animals; Dynorphins; Electroacupuncture; Injections, Spinal; Male; Muscle Spasticity; Parasympatholytics; Peptide Fragments; Rabbits; Random Allocation; Receptors, Opioid, kappa | 1994 |